Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Caribou Biosciences Inc (NASDAQ: CRBU) was $1.28 for the day, down -2.29% from the previous closing price of $1.31. In other words, the price has decreased by -$2.29 from its previous closing price. On the day, 1.0 million shares were traded.
Ratios:
Our analysis of CRBU’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.38 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on June 03, 2024, Downgraded its rating to In-line and sets its target price to $3 from $13 previously.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.Evercore ISI initiated its Outperform rating on October 31, 2023, with a $13 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 21 ’25 when MCCLUNG BARBARA G sold 3,564 shares for $1.35 per share. The transaction valued at 4,811 led to the insider holds 443,502 shares of the business.
Khan Ruhi Ahmad sold 3,564 shares of CRBU for $4,811 on Feb 21 ’25. The Chief Business Officer now owns 66,936 shares after completing the transaction at $1.35 per share. On Feb 21 ’25, another insider, Kanner Steven, who serves as the Chief Scientific Officer of the company, sold 3,564 shares for $1.35 each. As a result, the insider received 4,811 and left with 431,556 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.10 while its Price-to-Book (P/B) ratio in mrq is 0.41.
Stock Price History:
Over the past 52 weeks, CRBU has reached a high of $8.33, while it has fallen to a 52-week low of $1.22. The 50-Day Moving Average of the stock is -18.84%, while the 200-Day Moving Average is calculated to be -36.96%.
Shares Statistics:
A total of 90.55M shares are outstanding, with a floating share count of 79.17M. Insiders hold about 12.58% of the company’s shares, while institutions hold 60.03% stake in the company.
Earnings Estimates
As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.44 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.66 and -$1.75 for the fiscal current year, implying an average EPS of -$1.7. EPS for the following year is -$2.1, with 4.0 analysts recommending between -$1.64 and -$2.91.
Revenue Estimates
For the next quarter, 8 analysts are estimating revenue of $2.75M. There is a high estimate of $3.5M for the next quarter, whereas the lowest estimate is $2M.
